Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000012.xml
Endoscopy 2024; 56(10): v18
DOI: 10.1055/a-2335-1440
DOI: 10.1055/a-2335-1440
Author commentary
Author commentary on Shyam Menon et al.
Surveillance of Barrett’s esophagus (BE) based on p53 immunohistochemistry (IHC) was compared with conventional BE surveillance in a Markov model. Surveillance based on abnormal p53 IHC appeared to be cost-effective, with an incremental cost–effectiveness ratio (ICER) of $8258, and was associated with a 14% reduction in endoscopy burden and a 59% increase in dysplasia detection. This p53-based surveillance strategy will improve the cost-effectiveness and reduce the unnecessary burden of BE surveillance, both for patients and healthcare systems.
Quality:
Publication History
Article published online:
27 September 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany